MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Clinical trials for MUSCLE-INVASIVE UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new MUSCLE-INVASIVE UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for MUSCLE-INVASIVE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Personalized vaccine trial aims to stop aggressive bladder cancer from coming back

Disease control Recruiting now

This study is testing whether adding a personalized cancer vaccine (autogene cevumeran) to standard immunotherapy (nivolumab) can better prevent cancer from returning in patients with high-risk bladder cancer who have had surgery. The trial will enroll 362 participants who have h…

Matched conditions: MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Get alerted when new MUSCLE-INVASIVE UROTHELIAL CARCINOMA trials appear

Personalized vaccine trial aims to stop aggressive bladder cancer from coming back